Skip to main content
Omnicell, Inc. (OMCL)
NASDAQ: OMCL · Real-Time Price · USD
45.51
+7.88 (20.94%)
At close: Apr 28, 2026, 4:00 PM EDT
45.90
+0.39 (0.86%)
After-hours: Apr 28, 2026, 4:30 PM EDT

Omnicell Revenue

Omnicell had revenue of $309.88M in the quarter ending March 31, 2026, with 14.91% growth. This brings the company's revenue in the last twelve months to $1.23B, up 7.86% year-over-year. In the year 2025, Omnicell had annual revenue of $1.18B with 6.53% growth.

Revenue (ttm)
$1.23B
Revenue Growth
+7.86%
P/S Ratio
1.67
Revenue / Employee
$342,195
Employees
3,580
Market Cap
2.07B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251.18B72.61M6.53%
Dec 31, 20241.11B-34.87M-3.04%
Dec 31, 20231.15B-148.84M-11.48%
Dec 31, 20221.30B163.93M14.48%
Dec 31, 20211.13B239.81M26.88%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teladoc Health 2.53B
Privia Health Group 2.12B
GoodRx Holdings 796.85M
10x Genomics 642.82M
Doximity 637.78M
Hinge Health 587.86M
Certara 418.84M
Omada Health 260.21M
Revenue Rankings

OMCL News

More News